A simple, sensitive determination of ganciclovir in infant plasma by high-performance liquid chromatography with fluorescence detection

Journal of Chromatographic Science

Volumn 48, Issue 3, 2010, Pages 208-211

  Yoshida, Terumitsu ^a,b   Takahashi, Ryohei ^b   Imai, Koichi ^b   Uchida, Hiroshi ^c   Arai, Yasutoshi ^b   Oh Ishi, Tsutomu ^a,c  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b Department of Pharmacy ^*  (Japan)

^c Division of Infection and Immunology

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS;

EID: 77949302250     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.3.208     Document Type: Article

References (17)

1. D. Faulds and R.C. Heel. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 39(4): 597-638(1990).
2. T.C. Merigan, D.G. Renlund, S. Keay, M.R. Bristow, V. Starnes, J.B. O'Connell, S. Resta, D. Dunn, P. Gamberg, and R.M. Ratkovec. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. New Eng. J. Med. 326(18): 1182-1186 (1992).
3. D.C. Brennan, K.A. Garlock, G.G. Singer, M.A. Schnitzler, B.J. Lippmann, R.S. Buller, M. Gaudreault-Keener, J.A. Lowell, S. Shenoy, T.K. Howard, and G.A. Storch. Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients. Transplantation 64(12): 1843-1846 (1997).
4. G. Ancora, M. Lanari, T. Lazzarotto, V. Venturi, E. Tridapalli, F. Sandri, M. Menarini, E. Ferretti, and G. Faldella. Cranical ultrasound scanning and prediction of outcome in newborns with congenital cytomegalovirus infection. J. Pediatr. 150(2): 157-161 (2007).
5. S.A. Schraff, D.K. Brown, M.R. Schleiss, J. Meinzen-Der, J.H. Greinwald, and D.I. Choo. The role of CMV inflammatory genes in hearing loss. Otol. Neurotol. 28(7): 964-969 (2007).
6. D.W. Kimberlin, C.Y. Lin, P.J. Sanchez, G.J. Demmler, W. Dankner, M. Shelton, R.F. Jacobs, W. Vaudry, R.F. Pass, J.M. Kiell, S.J. Soong, and R.J. Whitley. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr. 143(1): 16-25 (2003).
7. M.A. Campanero, B. Sadaba, E. Garcia-Quetglas, and J.R. Azanza. Development and validation of a sensitive method for the determination of ganciclovir in human plasma samples by reversed-phase high-performance liquid chromatography. J. Chromatogr. B 706: 311-317 (1998).
8. M. Cociglio, H. Peyriere, D. Hillaire-Buys, and R. Alric. Application of a standardized coextractive clean up procedure to routine high-performance liquid chromatography assays of teicoplanin and ganciclovir in plasma. J. Chromatogr. B 705: 79-85 (1998).
9. S. Kishino, Y. Takekuma, M. Sugawara, H. Furukawa, S. Todo, and K. Miyazaki. Liquid chromatographic method for the determination of ganciclovir and/or acyclovir in human plasma using pulsed amperometric detection. J. Chromatogr. B 780: 289-294 (2002).
10. D. Teshima, K. otsubo, T. Yoshida, Y. Ito, and R. Oishi. A simple and simultaneous determination of acyclovir and ganciclovir in human plasma by high-performance liquid chromatography. Biomed. Chromatogr. 17: 500-503 (2003).
11. F. Chu, C-H. Kiang, M-L sung, B. Huang, R.L. Reeve, and T. Tarnowski. A rapid, sensitive HPLC method for the determination of ganciclovir in human plasma and serum. J. Pharmed. Biomed. Anal. 21: 657-667 (1999).
12. M. Tsuchie, S. Hara, M. Kimura, M. Fujii, N. Ono, and M. Kai. Determination of anti-virus drug, ganciclovir, in human serum by HPLC with precolumn fluorescence derivatization using phenylglyoxal. Anal. Sci. 17: 811-814 (2001).
13. N. Perrottet, A. Beguin, P. Meylan, M. Pascual, O. Manuel, T. Buclin, J. Biollaz, and L.A. Decostered. Determination of acyclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples. J. Chromatogr. B 852: 420-429 (2007).
14. Y.J. Dao, Z. Jiao, and M.K. Zhong. Simultaneous determination of acyclovir, ganciclovir, and penciclovir in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B 867: 270-216 (2008).
15. T. Page, C. Sherwood, J.D. Connor, and T. Tarnowski. Simple reversed-phase high -performance liquid chromatography quantitation of ganciclovir in human serum and urine. J. Chromatogr. B 675: 342-346 (1996).
16. M. Merodio, M.A. Campanero, T. Mirshahi, M. Mirshahi, and J.M. Irache. Development of a sensitive method for the determination of ganciclovir by reversed-phase high-performance liquid chromatography. J. Chromatogr. A 870: 159-167 (2000).
17. M. Burri, H. Wiltshire, C. Kahlert, G. Wouters, and C. Rudin. Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl. Pediatr. Infect. Dis. J. 23: 263-266 (2004)